Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Phil Markham"'
Autor:
Phil Markham, Ben Ollis, Joe Hagerman, Michael Starke, Pradeep Vitta, Justin Hill, Jeffrey D Munk, Teja Kuruganti, Christopher Winstead, Jennifer Burke, Ronald D. Ott, Joshua Hambrick, Drew Herron, Supriya Chinthavali, Helia Zandi, Jim Leverette, Heather Buckberry, Patrick Brukiewa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de002f07bcf4a3670153f0392e2220e1
https://doi.org/10.2172/1615193
https://doi.org/10.2172/1615193
Autor:
Genoveffa Franchini, Vanessa M. Hirsch, Derrick Martin, James G. McNally, Jim Tartaglia, Jay A. Berzofsky, Phil Markham, Mike Bray, Marcin Moniuszko, Yvette Edghill-Smith, Hana Golding, Tatiana S. Karpova, Wen-Po Tsai, Marsha J. Sowers, Elzbieta Tryniszewska, Jody Manischewitz, Mark G. Lewis, Igor M. Belyakov, David Venzon, Lisa R. King, Steven J. Snodgrass, Bernard Moss, Janos Nacsa, John Parrish
Publikováno v:
The Journal of Infectious Diseases. 188:1181-1191
We have modeled smallpox vaccination with Dryvax (Wyeth) in rhesus macaques that had depletion of CD4(+) T cells induced by infection with simian immunodeficiency virus or simian/human immunodeficiency virus. Smallpox vaccination induced significantl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea1378b115dfd3bd3b17097dea5cdb3d
https://doi.org/10.1086/378518
https://doi.org/10.1086/378518
Autor:
Gail P. Mazzara, Antonia Radaelli, Yvette Edghill-Smith, Wen Po Tsai, Elzbieta Tryniszewska, Veronica Elli, Carlo De Giuli Morghen, Phil Markham, Dennis Panicali, David Venzon, Carlo Zanotto, Genoveffa Franchini, Janos Nacsa
Publikováno v:
Virology. 312:181-195
A therapeutic vaccine for individuals infected with HIV-1 and treated with antiretroviral therapy (ART) should be able to replenish virus-specific CD4+ T-cells and broaden the virus-specific CD8+ T-cell response in order to maintain CD8+ T-cell funct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad0193dc2e4bc19b9e5fe49e017554e4
https://doi.org/10.1016/s0042-6822(03)00184-3
https://doi.org/10.1016/s0042-6822(03)00184-3
Autor:
Liljana Stevceva, Phil Markham, Genoveffa Franchini, Ruth F. Jarrett, Shigeki Takemoto, Emilia D. Rivadeneira, Maria Grazia Ferrari
Publikováno v:
Blood. 98:2193-2199
HVMNE is a novel Epstein-Barr (EBV)–like virus isolated from a Macaca nemestrina with CD8+ T-cell mycosis fungoides–cutaneous T-cell lymphoma. Here it is demonstrated that intravenous inoculation of irradiated HVMNE-infected T cells or cell-free
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e84d354e8fd842ff3bdf05f81028866
https://doi.org/10.1182/blood.v98.7.2193
https://doi.org/10.1182/blood.v98.7.2193
Autor:
Patricia Roth, Margherita Rosati, Agneta von Gegerfelt, George N. Pavlakis, David Venzon, Candido Alicea, Marjorie Robert-Guroff, Phil Markham, Antonio Valentin, Barbara K. Felber, David C. Montefiori
Publikováno v:
Journal of virology. 79(13)
We have tested the efficacy of DNA immunization as a single vaccination modality for rhesus macaques followed by highly pathogenic SIVmac251 challenge. To further improve immunogenicity of the native proteins, we generated expression vectors producin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::334f476ad8ee5805a31407c2d5166df1
https://pubmed.ncbi.nlm.nih.gov/15956591
https://pubmed.ncbi.nlm.nih.gov/15956591
Autor:
Julianna Lisziewicz, Jean-Paul Behr, Suresh K. Arya, Georg Varga, Patrick Erbacher, Cecil Fox, Jeffrey Trocio, Nyasha Bakare, Lucia Whitman, Ruth M. Woodward, Jianqing Xu, Franco Lori, Phil Markham
Publikováno v:
Journal of Investigative Dermatology
Journal of Investigative Dermatology, Nature Publishing Group, 2005, 124, pp.160-169
J. Invest. Dermatol.
J. Invest. Dermatol., 2005, 124, pp.160-169
Journal of Investigative Dermatology, Nature Publishing Group, 2005, 124, pp.160-169
J. Invest. Dermatol.
J. Invest. Dermatol., 2005, 124, pp.160-169
Human immunodeficiency virus (HIV) vaccines have the potential to improve antiretroviral drug treatment by inducing cytotoxic killing of HIV-infected cells. Prophylactic vaccines utilize new antigens to initiate immunity; however, in HIV-infected ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa30fa7949da2ad3efec7f8208e84ca6
https://hal.archives-ouvertes.fr/hal-00129913
https://hal.archives-ouvertes.fr/hal-00129913